For example, Tanoue et al. constructed an OAd with a helper-dependent Ad expressing a PD-L1 blocking mini-antibody and further confirmed its ability to significantly enhance HER2-specific CAR-T function in HER2 prostate cancer xenograft models [64]. Here, ERBB2 is linked to prostate cancer.